Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influvac vs Agrippal in Healthy Chinese Subjects
NCT00325260Phase 3Completed
- Sponsor
- Solvay
- Start
- Mar 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of subunit inactivated influenza vaccine in influenza, sponsored by Solvay. Started Mar 2006; status: completed.
02
Drugs
subunit inactivated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00325260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325260.